Chiu, Chao-Hua <br/><br/>
Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Aug 2007 
 - 213-21 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0169-5002 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2007.02.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--blood<br/>CA-125 Antigen--blood<br/>CA-19-9 Antigen--blood<br/>Carcinoembryonic Antigen--blood<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cohort Studies<br/>Female<br/>Gefitinib<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Predictive Value of Tests<br/>Quinazolines--therapeutic use<br/>Survival Analysis<br/>Treatment Outcome